June 4, 2024 Meeting of the Psychopharmacologic Drugs Advisory Committee (PDAC)

The Committee will discuss new drug application (NDA) 215455, for midomafetamine (MDMA), submitted by Lykos Therapeutics, …

source

by U.S. Food and Drug Administration

simple network management protocol